A Long Road to an RSV Antibody to Protect the Most Vulnerable
PositiveScience
Recent advancements in RSV immunization mark a significant breakthrough after decades of setbacks, including a tragic vaccine trial in the 1960s. Scientists have finally developed effective antibodies to protect the most vulnerable populations, particularly infants and the elderly. This progress is crucial as RSV can lead to severe respiratory issues, and these new developments could save countless lives and improve public health outcomes.
— Curated by the World Pulse Now AI Editorial System